Clinical status of antiprogesterone steroids.
D000021:Abortifacient Agents, Steroidal; D000028:Abortion, Induced; D000818:Animals; D001682:Biological Availability; D002986:Clinical Trials as Topic; D003271:Contraceptive Agents, Female; D003338:Corpus Luteum / Q000502:physiology; D004341:Drug Evaluation; D004717:Endometrium / Q000033:anatomy & histology / Q000187:drug effects / Q000502:physiology; D004958:Estradiol / Q000502:physiology; D004963:Estrenes / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007700:Kinetics; D007751:Labor, Induced; D008593:Menopause; D008598:Menstruation / Q000187:drug effects; D008600:Menstruation-Inducing Agents; D015735:Mifepristone; D010052:Ovariectomy; D010907:Pituitary Hormones / Q000097:blood; D011247:Pregnancy; D011374:Progesterone / Q000037:antagonists & inhibitors*; D011453:Prostaglandins / Q000096:biosynthesis; D011980:Receptors, Progesterone / Q000502:physiology; D014156:Transcortin / Q000378:metabolism
D000021:Abortifacient Agents, Steroidal; D003271:Contraceptive Agents, Female; D004963:Estrenes; D008600:Menstruation-Inducing Agents; D010907:Pituitary Hormones; D011453:Prostaglandins; D011980:Receptors, Progesterone; D015735:Mifepristone; C048260:lilopristone; D011374:Progesterone; D004958:Estradiol; D014156:Transcortin; D006854:Hydrocortisone